| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000348587 |
| P698 | PubMed publication ID | 23942342 |
| P2093 | author name string | Csilla Putz-Bankuti | |
| Rudolf Stauber | |||
| Andreas Meinitzer | |||
| Hans-Peter Kapfhammer | |||
| Hans-Bernd Rothenhäusler | |||
| Andreas Baranyi | |||
| Robert J Breitenecker | |||
| Alexandra Stepan | |||
| P2860 | cites work | An Inventory for Measuring Depression | Q26778503 |
| Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction | Q27477533 | ||
| Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior | Q28508390 | ||
| Development of a Rating Scale for Primary Depressive Illness | Q29616244 | ||
| The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity | Q32043227 | ||
| CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression | Q33751166 | ||
| Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review | Q33930192 | ||
| Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis | Q34642429 | ||
| The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans | Q35017005 | ||
| Drug-induced depression: a systematic review to inform clinical practice | Q35796768 | ||
| Depression, anemia and health-related quality of life in chronic hepatitis C. | Q40356777 | ||
| Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection | Q42556402 | ||
| Depression severity and drug injection HIV risk behaviors | Q42607096 | ||
| Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study | Q43269486 | ||
| Clinimetrics and clinical psychometrics: macro- and micro-analysis | Q43794534 | ||
| Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system | Q43859445 | ||
| Hepatitis C and Depressive Symptoms: Psychological and Social Factors Matter More Than Liver Injury | Q43958100 | ||
| Emotional stress, psychosocial variables and coping associated with hepatitis C virus and human immunodeficiency virus infections in intravenous drug users | Q43971317 | ||
| Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a | Q44403521 | ||
| Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. | Q44906505 | ||
| IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity | Q45115322 | ||
| Analysis of plasma amino acids by HPLC with photodiode array and fluorescence detection | Q45302536 | ||
| Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study | Q45423070 | ||
| Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus | Q45730010 | ||
| Three cases of successful tryptophan add-on or monotherapy of hepatitis C and IFNalpha-associated mood disorders | Q46365371 | ||
| Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy | Q47861479 | ||
| Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C. | Q48690015 | ||
| Assessment of psychological distress in the setting of medical disease. | Q51065539 | ||
| Prevalence of hepatitis C among psychiatric patients in the public sector. | Q51951423 | ||
| P433 | issue | 5 | |
| P921 | main subject | chronic hepatitis C | Q55779873 |
| P304 | page(s) | 332-340 | |
| P577 | publication date | 2013-08-09 | |
| P1433 | published in | Psychotherapy and Psychosomatics | Q15767307 |
| P1476 | title | A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection | |
| P478 | volume | 82 |
| Q35619107 | A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C. |
| Q92783333 | An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder |
| Q89493771 | Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential |
| Q30355874 | Association of Changes in Mood Status and Psychosocial Well-Being with Depression During Interferon-Based Treatment for Hepatitis C. |
| Q42239297 | Baseline Comorbidities Enhance the Risk of Treatment-Induced Depression in HCV-Infected Men: A Pilot Study |
| Q37690195 | Beta-trace Protein as a new non-invasive immunological Marker for Quinolinic Acid-induced impaired Blood-Brain Barrier Integrity |
| Q36095093 | Branched-Chain Amino Acids as New Biomarkers of Major Depression - A Novel Neurobiology of Mood Disorder. |
| Q26783698 | Depression and suicide ideation in chronic hepatitis C patients untreated and treated with interferon: prevalence, prevention, and treatment |
| Q47111657 | Evaluation of the effect of soybean diet on interferon-α-induced depression in male mice |
| Q37114639 | Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies |
| Q60049195 | Metabolomics approach in the investigation of depression biomarkers in pharmacologically induced immune-related depression |
| Q28607691 | Quinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory Hypothesis |
| Q47163480 | Revisiting the tryptophan-serotonin deficiency and the inflammatory hypotheses of major depression in a biopsychosocial approach |
| Q39014560 | Sexual dysfunction and dissatisfaction in chronic hepatitis C patients |
Search more.